<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13</volume><submitter>Chen YJ</submitter><pubmed_abstract>&lt;h4>Objective&lt;/h4>To systematically evaluate the efficacy of transcutaneous electrical acupoint stimulation (TEAS) in preventing postoperative delirium (POD) in elderly patients undergoing various surgical procedures.&lt;h4>Methods&lt;/h4>A comprehensive literature search was conducted across multiple electronic databases to identify randomized controlled trials (RCTs) comparing TEAS with control interventions (sham or no stimulation) in patients aged >60 years undergoing surgery. The primary outcome was the incidence of POD within the first seven postoperative days. Meta-analysis was performed using RevMan software, calculating risk ratios (RR), mean differences (MD), or standard MD with 95% confidence intervals (CIs). The quality of evidence was assessed based on the Grading of Recommendations Assessment, Development, and Evaluation approach.&lt;h4>Results&lt;/h4>Twenty RCTs involving 2,290 patients (aged >60 years) were included. The overall incidence of POD was 5.6% in the TEAS group compared to 17.0% in the control group (RR 0.34, 95% CI 0.26-0.45). TEAS also significantly reduced CAM score (MD -1.01, 95% CI -1.98 to -0.04), propofol consumption (MD -35.59 mg, 95% CI -65.75 to -5.42), postoperative pain score (MD -0.60, 95% CI -1.02 to -0.18), and improved recovery quality (QoR-15 score: MD 23.76, 95% CI 21.72-25.80). The intervention appeared safe with no serious adverse events reported.&lt;h4>Conclusion&lt;/h4>Perioperative TEAS application significantly reduces the risk of POD in elderly surgical patients. Its protective effects are potentially mediated through anti-inflammatory effects. TEAS represents a promising non-pharmacological intervention for POD prevention within enhanced recovery protocols.&lt;h4>Systematic review registration&lt;/h4>CRD420251128976.</pubmed_abstract><journal>Frontiers in medicine</journal><pagination>1717702</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12852452</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Transcutaneous electrical acupoint stimulation for preventing postoperative delirium in elderly patients: a systematic review and meta-analysis.</pubmed_title><pmcid>PMC12852452</pmcid><pubmed_authors>Yang Y</pubmed_authors><pubmed_authors>Shen QH</pubmed_authors><pubmed_authors>Chen YJ</pubmed_authors><pubmed_authors>Shen R</pubmed_authors><pubmed_authors>Li HF</pubmed_authors></additional><is_claimable>false</is_claimable><name>Transcutaneous electrical acupoint stimulation for preventing postoperative delirium in elderly patients: a systematic review and meta-analysis.</name><description>&lt;h4>Objective&lt;/h4>To systematically evaluate the efficacy of transcutaneous electrical acupoint stimulation (TEAS) in preventing postoperative delirium (POD) in elderly patients undergoing various surgical procedures.&lt;h4>Methods&lt;/h4>A comprehensive literature search was conducted across multiple electronic databases to identify randomized controlled trials (RCTs) comparing TEAS with control interventions (sham or no stimulation) in patients aged >60 years undergoing surgery. The primary outcome was the incidence of POD within the first seven postoperative days. Meta-analysis was performed using RevMan software, calculating risk ratios (RR), mean differences (MD), or standard MD with 95% confidence intervals (CIs). The quality of evidence was assessed based on the Grading of Recommendations Assessment, Development, and Evaluation approach.&lt;h4>Results&lt;/h4>Twenty RCTs involving 2,290 patients (aged >60 years) were included. The overall incidence of POD was 5.6% in the TEAS group compared to 17.0% in the control group (RR 0.34, 95% CI 0.26-0.45). TEAS also significantly reduced CAM score (MD -1.01, 95% CI -1.98 to -0.04), propofol consumption (MD -35.59 mg, 95% CI -65.75 to -5.42), postoperative pain score (MD -0.60, 95% CI -1.02 to -0.18), and improved recovery quality (QoR-15 score: MD 23.76, 95% CI 21.72-25.80). The intervention appeared safe with no serious adverse events reported.&lt;h4>Conclusion&lt;/h4>Perioperative TEAS application significantly reduces the risk of POD in elderly surgical patients. Its protective effects are potentially mediated through anti-inflammatory effects. TEAS represents a promising non-pharmacological intervention for POD prevention within enhanced recovery protocols.&lt;h4>Systematic review registration&lt;/h4>CRD420251128976.</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026</publication><modification>2026-06-20T03:18:45.966Z</modification><creation>2026-06-20T03:09:38.679Z</creation></dates><accession>S-EPMC12852452</accession><cross_references><pubmed>41626221</pubmed><doi>10.3389/fmed.2026.1717702</doi></cross_references></HashMap>